Nightingale Health Oyj
F:7XE
Relative Value
The Relative Value of one 7XE stock under the Base Case scenario is 0.52 EUR. Compared to the current market price of 1.87 EUR, Nightingale Health Oyj is Overvalued by 72%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
7XE Competitors Multiples
Nightingale Health Oyj Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
FI |
Nightingale Health Oyj
F:7XE
|
112.8m EUR | 27 | -6.2 | -3 | -1.9 | ||
US |
Cigna Corp
NYSE:CI
|
98.7B USD | 0.5 | 27.3 | 9.8 | 13 | ||
US |
C
|
Cigna Group
XMUN:CGN
|
91.3B EUR | 0.5 | 27.1 | 9.8 | 12.9 | |
US |
CVS Health Corp
NYSE:CVS
|
68.7B USD | 0.2 | 9.4 | 8.6 | 8.6 | ||
DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
16B EUR | 0.7 | -27 | 10.2 | 22.8 | |
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
17B USD | 1.4 | 39.2 | 11.9 | 18 | ||
US |
Quest Diagnostics Inc
NYSE:DGX
|
15.1B USD | 1.6 | 17.9 | 10.7 | 14.5 | ||
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.3B EUR | 0.6 | 22.7 | 6.8 | 16.1 | |
US |
DaVita Inc
NYSE:DVA
|
11.9B USD | 1 | 14.6 | 8.2 | 11.8 | ||
DE |
Fresenius Medical Care AG
XMUN:FME
|
11B EUR | 0.6 | 22 | 6.7 | 15.9 | ||
US |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 4.4 | -18.6 | -23.3 | -21.5 |